| Michael T Swinyard, MD | |
|
1258 W South Jordan Pkwy Ste 103, South Jordan, UT 84095-4712 | |
| (801) 838-9090 | |
| (801) 838-9092 |
| Full Name | Michael T Swinyard |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Endocrinology |
| Location | 1258 W South Jordan Pkwy Ste 103, South Jordan, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245222819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0205X | Pediatrics - Pediatric Endocrinology | 292580-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael T Swinyard, MD 1258 W S Jordan Pkwy Ste 103, South Jordan, UT 84095-4712 Ph: (801) 838-9090 | Michael T Swinyard, MD 1258 W South Jordan Pkwy Ste 103, South Jordan, UT 84095-4712 Ph: (801) 838-9090 |
News Archive
A new blood stabilization method, developed at the Massachusetts General Hospital Center for Engineering in Medicine, significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare circulating tumor cells (CTCs), living cancer cells carried in the bloodstream.
Group Health has been approved for two research awards from the Patient-Centered Outcomes Research Institute (PCORI) to study ways to improve care for back pain and to connect patients with community resources. The projects are part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.
Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its new balloon expandable stent for renal artery disease. Intended for patients suffering from renal artery stenosis, a narrowing of the arteries that supply blood to the kidneys, the new device features a low profile design and does not shorten upon expansion.
A new genetic defect that predisposes people to acute myeloid leukemia and myelodysplasia has been discovered. The mutations were found in the GATA2 gene. Among its several regulatory roles, the gene acts as a master control during the transition of primitive blood-forming cells into white blood cells.
› Verified 4 days ago
Dr. Sarah Connors Petersen, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5126 W Daybreak Pkwy, South Jordan, UT 84095 Phone: 801-213-4500 Fax: 801-213-4509 | |
Lindsi Mccoard Roundy, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1268 W South Jordan Pkwy Ste 201, South Jordan, UT 84095 Phone: 801-254-9700 | |
Michelle Elizabeth Murray, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3556 W 9800 S, Suite 101, South Jordan, UT 84095 Phone: 801-567-9780 Fax: 801-567-9826 | |
Dr. Nathan Bexfield, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5126 W Daybreak Pkwy, South Jordan, UT 84095 Phone: 801-213-4500 Fax: 801-213-5368 | |
Keith Ramsey, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 4105 W Shinnerock Dr, South Jordan, UT 84009 Phone: 801-518-6973 | |
Dr. Kathy Stretch Garcia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3556 W 9800 S Ste 101, South Jordan, UT 84095 Phone: 801-567-9780 Fax: 801-567-9826 |